BIO-TECHNE Corp — Director's Dealing 2021

Nov 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-11-01

Reporting Person: Hippel James (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01	Common Stock	M	8822	$125.05	Acquired	19577	Direct
2021-11-01	Common Stock	S	3566	$525.6081	Disposed	16011	Direct
2021-11-01	Common Stock	S	2880	$526.5005	Disposed	13131	Direct
2021-11-01	Common Stock	S	1433	$527.4969	Disposed	11698	Direct
2021-11-01	Common Stock	S	943	$528.5544	Disposed	10755	Direct
2021-11-02	Common Stock	M	200	$125.05	Acquired	10955	Direct
2021-11-02	Common Stock	S	200	$525.1	Disposed	10755	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-01	Stock Options (Right to Buy)	$125.05	M	8822	Disposed	2024-08-09	Common Stock (8822)	Direct
2021-11-02	Stock Options (Right to Buy)	$125.05	M	200	Disposed	2024-08-09	Common Stock (200)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (18066)	18066	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (24089)	24089	Direct
Restricted Stock Units	$		Common Stock (3938)	3938	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (19936)	19936	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (26581)	26581	Direct
Restricted Stock Units	$		Common Stock (3219)	3219	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (14360)	14360	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (19147)	19147	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (8325)	8325	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (8325.0)	8325.0	Direct
Restricted Stock Units	$		Common Stock (1945)	1945	Direct
Stock Options (Right to Buy)	$481.82	2028-08-06	Common Stock (7600)	7600	Direct
Stock Options (Right to Buy)	$481.82	2028-08-06	Common Stock (10134)	10134	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.10 to $526.09, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.105 to $527.08, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.14 to $528.00, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.16 to $528.995, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

F7: Fully exercisable.

F8: Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.

F9: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F10: Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.

F11: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F12: Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.

F13: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.

F14: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

F15: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F16: Options to purchase 2,534 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vest on each of 8/6/2024 and 8/6/2025.